https://corporate.abcam.com/wp-content/uploads/2022/03/CiteAb22-PN.jpg350500Pierre Peotta/wp-content/uploads/2020/07/logo.pngPierre Peotta2022-03-24 10:48:422022-03-25 14:43:07Abcam the Most Awarded Company at 2022 Industry Awards
https://corporate.abcam.com/wp-content/uploads/2022/03/FY2021-PN.jpg350500Pierre Peotta/wp-content/uploads/2020/07/logo.pngPierre Peotta2022-03-14 09:44:502022-03-14 12:12:53Results for the 12- and 18-month periods ended 31 December 2021
https://corporate.abcam.com/wp-content/uploads/2021/01/Flags-PN.jpg350500Pierre Peotta/wp-content/uploads/2020/07/logo.pngPierre Peotta2022-02-01 09:32:222022-02-01 09:33:43Trading update for the period ended 31 December 2021
https://corporate.abcam.com/wp-content/uploads/2022/01/Alliance-logo-PN.jpg350500Pierre Peotta/wp-content/uploads/2020/07/logo.pngPierre Peotta2022-02-01 08:55:502022-02-01 09:15:25Abcam collaborates with Twist Bioscience to enhance antibody discovery for diagnostic and research applications
https://corporate.abcam.com/wp-content/uploads/2022/01/Glassdoor-2022-PN.png350500Pierre Peotta/wp-content/uploads/2020/07/logo.pngPierre Peotta2022-01-11 16:54:382022-01-12 11:30:08Abcam in Glassdoor’s Top 5 Best Places to Work in the UK for Second Consecutive Year
https://corporate.abcam.com/wp-content/uploads/2021/12/Alliance-logo-PN.jpg350500Pierre Peotta/wp-content/uploads/2020/07/logo.pngPierre Peotta2022-01-04 08:59:232022-01-05 19:29:17Alamar Biosciences partners with Abcam to drive understanding of the human proteome
https://corporate.abcam.com/wp-content/uploads/2021/10/Alliance-logo-PN.jpg350500Pierre Peotta/wp-content/uploads/2020/07/logo.pngPierre Peotta2021-11-02 12:00:152021-11-02 12:00:15Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
https://corporate.abcam.com/wp-content/uploads/2021/09/Inv-Pres-news-Sept-2021-BN.jpg350500Pierre Peotta/wp-content/uploads/2020/07/logo.pngPierre Peotta2021-09-13 12:29:422021-09-13 12:58:00Interim results for the 6- and 12-month periods ended 30 June 2021
https://corporate.abcam.com/wp-content/uploads/2021/08/GE-v-PN.jpg350500connective/wp-content/uploads/2020/07/logo.pngconnective2021-08-02 07:00:122021-11-09 17:00:25Abcam to acquire BioVision for $340 million
https://corporate.abcam.com/wp-content/uploads/2021/07/Waltham-PN.jpg350500Pierre Peotta/wp-content/uploads/2020/07/logo.pngPierre Peotta2021-07-13 11:15:502021-07-13 12:33:49Abcam opens new US facility in Boston, MA
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Google Analytics Cookies
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
The following cookies are also needed - You can choose if you want to allow them: